Drug Profile
Cidofovir - Uteron Pharma
Alternative Names: C1; ColvirLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator Mithra Pharmaceuticals; Uteron Pharma
- Developer Uteron Pharma
- Class Antivirals; Phosphonic acids; Pyrimidinones; Small molecules
- Mechanism of Action DNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cervical intraepithelial neoplasia; Human papillomavirus infections
Most Recent Events
- 08 May 2020 Allergan has been acquired and merged into AbbVie
- 17 Feb 2016 No recent reports on development identified - Phase-II for Cervical intraepithelial neoplasia in Belgium (Topical)
- 17 Feb 2016 No recent reports on development identified - Phase-II for Human papillomavirus infections in Belgium (Topical)